phaseolus vulgaris leucoagglutinin pha l (Vector Laboratories)
Vector Laboratories is a verified supplier 
Vector Laboratories manufactures this product 
93
Structured Review
Vector Laboratories
phaseolus vulgaris leucoagglutinin pha l
Phaseolus Vulgaris Leucoagglutinin Pha L, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/FL-1111-2/Fluorescein+labeled+Phaseolus+Vulgaris+Leucoagglutinin+(PHA-L)/pmc12551146-91-1-6
Average 93 stars, based on 31 article reviews
Phaseolus Vulgaris Leucoagglutinin Pha L, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/FL-1111-2/Fluorescein+labeled+Phaseolus+Vulgaris+Leucoagglutinin+(PHA-L)/pmc12551146-91-1-6
Average 93 stars, based on 31 article reviews
phaseolus vulgaris leucoagglutinin pha l - by Bioz Stars,
2026-11
93/100 stars
Images
Related Articles
Derivative Assay:Article Title: Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples OVJ-1 Experimental Tissue Shared Resource, UCI N/A OVJ-2 Experimental Tissue Shared Resource, UCI N/A Patient derived metastatic Ewing’s Sarcoma Experimental Tissue Shared Resource, UCI 31461 Patient derived metastatic Colon Adenocarcinoma Experimental Tissue Shared Resource, UCI 31004 Colorectal Carcinoma Progression TMA Cooperative Human Tissue Network, University of Virginia CHTN_CRC2 Normal human tissue microarray BioMAx FDA999u Normal human tissue microarray BioMAx FDA999w Normal human tissue microarray US Biolabs FDA999-1 Prostate cancer microarray Novus Biologicals NBP2-30169 Breast cancer microarray BioMAx BR1005b Chemicals, peptides, and recombinant proteins Tn antigen Sigma 53886 GalNAc Sigma A2795 GlcNAc Wellesley Therapeutics Ultimate Glucosamine® Kifunensine GlycoSyn FC-034 D-Luciferin PerkinElmer 122799 GlyTR gene synthesis and plasmids Genscript/ProBio This paper CD301-6xHistidine R&D Systems 4888-CL-050 L-PHA, Fluorescein Vector Laboratories FL-1111; RRID: AB_2336655 L-PHA-Biotin Vector Laboratories B-1115; RRID: Microarray:Article Title: Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples OVJ-1 Experimental Tissue Shared Resource, UCI N/A OVJ-2 Experimental Tissue Shared Resource, UCI N/A Patient derived metastatic Ewing’s Sarcoma Experimental Tissue Shared Resource, UCI 31461 Patient derived metastatic Colon Adenocarcinoma Experimental Tissue Shared Resource, UCI 31004 Colorectal Carcinoma Progression TMA Cooperative Human Tissue Network, University of Virginia CHTN_CRC2 Normal human tissue microarray BioMAx FDA999u Normal human tissue microarray BioMAx FDA999w Normal human tissue microarray US Biolabs FDA999-1 Prostate cancer microarray Novus Biologicals NBP2-30169 Breast cancer microarray BioMAx BR1005b Chemicals, peptides, and recombinant proteins Tn antigen Sigma 53886 GalNAc Sigma A2795 GlcNAc Wellesley Therapeutics Ultimate Glucosamine® Kifunensine GlycoSyn FC-034 D-Luciferin PerkinElmer 122799 GlyTR gene synthesis and plasmids Genscript/ProBio This paper CD301-6xHistidine R&D Systems 4888-CL-050 L-PHA, Fluorescein Vector Laboratories FL-1111; RRID: AB_2336655 L-PHA-Biotin Vector Laboratories B-1115; RRID: Recombinant:Article Title: Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples OVJ-1 Experimental Tissue Shared Resource, UCI N/A OVJ-2 Experimental Tissue Shared Resource, UCI N/A Patient derived metastatic Ewing’s Sarcoma Experimental Tissue Shared Resource, UCI 31461 Patient derived metastatic Colon Adenocarcinoma Experimental Tissue Shared Resource, UCI 31004 Colorectal Carcinoma Progression TMA Cooperative Human Tissue Network, University of Virginia CHTN_CRC2 Normal human tissue microarray BioMAx FDA999u Normal human tissue microarray BioMAx FDA999w Normal human tissue microarray US Biolabs FDA999-1 Prostate cancer microarray Novus Biologicals NBP2-30169 Breast cancer microarray BioMAx BR1005b Chemicals, peptides, and recombinant proteins Tn antigen Sigma 53886 GalNAc Sigma A2795 GlcNAc Wellesley Therapeutics Ultimate Glucosamine® Kifunensine GlycoSyn FC-034 D-Luciferin PerkinElmer 122799 GlyTR gene synthesis and plasmids Genscript/ProBio This paper CD301-6xHistidine R&D Systems 4888-CL-050 L-PHA, Fluorescein Vector Laboratories FL-1111; RRID: AB_2336655 L-PHA-Biotin Vector Laboratories B-1115; RRID: Labeling:Article Title: Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples OVJ-1 Experimental Tissue Shared Resource, UCI N/A OVJ-2 Experimental Tissue Shared Resource, UCI N/A Patient derived metastatic Ewing’s Sarcoma Experimental Tissue Shared Resource, UCI 31461 Patient derived metastatic Colon Adenocarcinoma Experimental Tissue Shared Resource, UCI 31004 Colorectal Carcinoma Progression TMA Cooperative Human Tissue Network, University of Virginia CHTN_CRC2 Normal human tissue microarray BioMAx FDA999u Normal human tissue microarray BioMAx FDA999w Normal human tissue microarray US Biolabs FDA999-1 Prostate cancer microarray Novus Biologicals NBP2-30169 Breast cancer microarray BioMAx BR1005b Chemicals, peptides, and recombinant proteins Tn antigen Sigma 53886 GalNAc Sigma A2795 GlcNAc Wellesley Therapeutics Ultimate Glucosamine® Kifunensine GlycoSyn FC-034 D-Luciferin PerkinElmer 122799 GlyTR gene synthesis and plasmids Genscript/ProBio This paper CD301-6xHistidine R&D Systems 4888-CL-050 L-PHA, Fluorescein Vector Laboratories FL-1111; RRID: AB_2336655 L-PHA-Biotin Vector Laboratories B-1115; RRID: Control:Article Title: Safe immunosuppression-resistant pan-cancer immunotherapeutics by velcro-like density-dependent targeting of tumor-associated carbohydrate antigens. Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples OVJ-1 Experimental Tissue Shared Resource, UCI N/A OVJ-2 Experimental Tissue Shared Resource, UCI N/A Patient derived metastatic Ewing’s Sarcoma Experimental Tissue Shared Resource, UCI 31461 Patient derived metastatic Colon Adenocarcinoma Experimental Tissue Shared Resource, UCI 31004 Colorectal Carcinoma Progression TMA Cooperative Human Tissue Network, University of Virginia CHTN_CRC2 Normal human tissue microarray BioMAx FDA999u Normal human tissue microarray BioMAx FDA999w Normal human tissue microarray US Biolabs FDA999-1 Prostate cancer microarray Novus Biologicals NBP2-30169 Breast cancer microarray BioMAx BR1005b Chemicals, peptides, and recombinant proteins Tn antigen Sigma 53886 GalNAc Sigma A2795 GlcNAc Wellesley Therapeutics Ultimate Glucosamine® Kifunensine GlycoSyn FC-034 D-Luciferin PerkinElmer 122799 GlyTR gene synthesis and plasmids Genscript/ProBio This paper CD301-6xHistidine R&D Systems 4888-CL-050 L-PHA, Fluorescein Vector Laboratories FL-1111; RRID: AB_2336655 L-PHA-Biotin Vector Laboratories B-1115; RRID: |